JPS58219196A - Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucoside - Google Patents
Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucosideInfo
- Publication number
- JPS58219196A JPS58219196A JP10138982A JP10138982A JPS58219196A JP S58219196 A JPS58219196 A JP S58219196A JP 10138982 A JP10138982 A JP 10138982A JP 10138982 A JP10138982 A JP 10138982A JP S58219196 A JPS58219196 A JP S58219196A
- Authority
- JP
- Japan
- Prior art keywords
- demethyl
- epipodophyllotoxin
- formula
- group
- halogenoethoxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は4′−ハロゲノエトキシカルボニルー4′−デ
メチル−エピポドフィロトキシン−β−D −2−3−
ジー0−アシル−4・6−エテリデングルコシド(T)
のアシル基ヲアルコリシスにより、又ハロゲンエトキシ
カルボニル基を還元によす除去することを特徴とする4
′−デメチルエピポドフィロトキシン−β−り一エテリ
デングルコシド(It)の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides 4'-halogenoethoxycarbonyl-4'-demethyl-epipodophyllotoxin-β-D-2-3-
Di-0-acyl-4,6-etheridene glucoside (T)
4, characterized in that the acyl group is removed by alcoholysis, and the halogen ethoxycarbonyl group is removed by reduction.
The present invention relates to a method for producing '-demethylepipodophyllotoxin-β-ri-etheridene glucoside (It).
〔式中Acはアシル基を、msはメチル基を、Xけハロ
ゲンを示し、mはO−2の整数、nは1−3の整数であ
り、かつm +n = 3である〕上記式(Dで示され
る化合物は抗腫瘍活性を有する植物成分ポドフィロトキ
シンから誘導される新規物質であり、又、上記式(U)
で示される化合物はvP−16と呼ばれ抗腫瘍活性を有
し、制癌剤として有用な物質である。[In the formula, Ac represents an acyl group, ms represents a methyl group, X represents a halogen, m is an integer of O-2, n is an integer of 1-3, and m + n = 3] The above formula ( The compound represented by D is a new substance derived from the plant component podophyllotoxin having antitumor activity, and is also a compound represented by the above formula (U).
The compound represented by is called vP-16, has antitumor activity, and is a useful substance as an anticancer agent.
化合物(U)の製造法としては次の工程によるものが既
に知られている。(特公昭46−3’i’83’7号公
報参照)
c式中Rはポルミル又はアセチル、mθは前記と同じ、
φはフェニル基を示す。)
ら
しかしなかゆこの方法はカルボベンゾキシ基を除去する
に当り、パラジウム−木炭を触媒に用いる為に、大量の
合成の場合反応が完結しにくがったり、又触媒除去の際
発火等の危険性がある等の欠点を有しており、工業的製
法としては好ましくない0
そこで本発明者らは上記欠点のない化合物(n)の製法
について種々検討した結果、式(I)で示される化合物
を原料とすると、大量合成の場合でも容易に、しかも安
全に、収率よく化合物(…)が製造できることを見い出
した。The following process is already known as a method for producing compound (U). (Refer to Japanese Patent Publication No. 46-3'i'83'7) In the c formula, R is polmyl or acetyl, mθ is the same as above,
φ represents a phenyl group. ) When removing the carbobenzoxy group, Nakayuko's method uses palladium-charcoal as a catalyst, which makes it difficult to complete the reaction when a large amount is synthesized, and may cause ignition when removing the catalyst. Therefore, the present inventors have conducted various studies on methods for producing compound (n) that do not have the above drawbacks, and have found that the compound (n) shown by formula (I) has disadvantages such as the risk of We have discovered that the compound (...) can be produced easily, safely, and with good yield even in the case of large-scale synthesis by using the compound (...) as a raw material.
本発明は上記知見に基づいて完成されたものである。The present invention was completed based on the above findings.
本発明において、2位および3位のアシル基としては例
えばアセチル基、ホルミル基などがあげられる。In the present invention, examples of the acyl groups at the 2- and 3-positions include an acetyl group and a formyl group.
又、4’−位のハロゲノエトキシカルボニル基としては
そのβ−位に塩素、臭素、ヨウ素を1−3個有するもの
が好ましく、例えばβ−アイオドエトキシカルボニル基
、乙β−ジクロロエトキシカルボニル基、β、β、β−
トリクロロエトキシカル′ボニル基、β、β、β−トリ
ブロモエトキシカルボニル基などがあげられるが、β、
β、β−トリクロロエトキシカルボニル基が好ましい。Further, as the halogenoethoxycarbonyl group at the 4'-position, one having 1 to 3 chlorine, bromine, or iodine at the β-position is preferable, such as a β-iodoethoxycarbonyl group, a β-dichloroethoxycarbonyl group, β, β, β−
Examples include trichloroethoxycarbonyl group, β, β, β-tribromoethoxycarbonyl group, etc.
A β,β-trichloroethoxycarbonyl group is preferred.
本発明におけるアルコリシスおよび還元は任意の順序で
、又は両者同時に行うことができる。Alcoholysis and reduction in the present invention can be performed in any order or both at the same time.
アルコリシスは例えばメタノール、エタノールなどのア
ルコール類、又はそれらとジオキサン、テトラヒドロフ
ランなどとの混合溶媒中、無水酢酸亜鉛の存在下に20
−30時間加熱還流することにより行なわれる。Alcoholysis is carried out in the presence of anhydrous zinc acetate in an alcohol such as methanol, ethanol, or a mixed solvent of these and dioxane, tetrahydrofuran, etc.
- This is carried out by heating under reflux for 30 hours.
還元は例えば電解還元法により、又は亜鉛系の触媒を用
いる方法などにより行なわれる。亜鉛系の触媒としては
例えば亜鉛末、亜鉛−銅、亜鉛−銀、亜鉛−水銀などを
あげることができる。その使用iハ化合物(1) ニ対
t、、50−100 W/W %程度で充分である。又
、溶媒としては酢酸、メタノール、エタノールが使用さ
れ、場合により補助溶媒として水、ジオキサン、テトラ
ヒドロフランなどを用いてもよい。反応温度は特に限定
されないが酢酸の場合は0℃〜室温、アルコールの場合
は還流温度で行なわれる。反応に要する時間は用いる溶
媒、温度により異なるが15分〜2時間である。The reduction is carried out, for example, by an electrolytic reduction method or by a method using a zinc-based catalyst. Examples of zinc-based catalysts include zinc powder, zinc-copper, zinc-silver, and zinc-mercury. It is sufficient to use the compound (1) in an amount of about 50-100 W/W%. In addition, acetic acid, methanol, and ethanol are used as the solvent, and water, dioxane, tetrahydrofuran, etc. may be used as an auxiliary solvent depending on the case. The reaction temperature is not particularly limited, but in the case of acetic acid it is carried out at 0°C to room temperature, and in the case of alcohol it is carried out at reflux temperature. The time required for the reaction varies depending on the solvent and temperature used, but is from 15 minutes to 2 hours.
又、アルコリシスおよび還元を同時に実施する場合は、
例えば化合物(1)を亜鉛末および無水酢酸亜鉛の存在
下、メタノールなどのアルコール類又はそれらとジオキ
サン、テトラヒドロフランとの混合溶媒中で20〜30
時間加熱還流すればよい。In addition, when carrying out alcoholysis and reduction at the same time,
For example, compound (1) is mixed in an alcohol such as methanol or a mixed solvent of these with dioxane or tetrahydrofuran in the presence of zinc dust and anhydrous zinc acetate for 20 to 30%
It may be heated under reflux for a period of time.
本発明において出発原料として使用する式(1)れる4
′−デメテルーエビボドフイロトキシン(IV)(特公
昭43−6 ’469号公報参照)を原料とし、例えば
次の反応経路を経て合成される。Formula (1) used as a starting material in the present invention 4
It is synthesized using, for example, the following reaction route using '-demeter-evivodophyllotoxin (IV) (see Japanese Patent Publication No. 43-6 '469) as a raw material.
(V)
□ (1)
〔式中AC,mθは前記と同じ〕
即ち、4′−デメチル−エピポドフィロトキシン(IV
)に不活性溶媒中でβ、β2β−トリクロルエトキシカ
ルボニルクロリドを反応させて得られる4′−β、β。(V) □ (1) [In the formula, AC and mθ are the same as above] That is, 4'-demethyl-epipodophyllotoxin (IV
) with β,β2β-trichloroethoxycarbonyl chloride in an inert solvent.
β−トリクロルエトキシカルボニル−4′−デメテルー
エピボドフイロトキシン(V)を三弗化硼素エチルエー
テレートの存在下、不活性な有機溶媒中、0℃より低い
温度で4.6−0−エチリデン−2,3−ジー0−アシ
ル−β−D−fルコヒラノースト縮合嘔せることにより
(1)を合成した。β-Trichloroethoxycarbonyl-4'-demeter-epibodophyllotoxin (V) in the presence of boron trifluoride ethyl etherate in an inert organic solvent at a temperature below 0°C. (1) was synthesized by condensation of ethylidene-2,3-di-0-acyl-β-Dfrucohylanost.
以下に実施例並びに参考例を挙げて本発明を具体的に説
明する。The present invention will be specifically explained below with reference to Examples and Reference Examples.
実施例1
4′−デメテルーエビボドフイロトキシン−β−D−エ
チリデングルコシドの製法
4′−β、β、β−トリクロルエトキシカルボニル−4
′−デメチルーエビポドフイロトキシ/−β−り一2,
3−ジー0−7セチルー4.6−エチリデングルコシド
(100wq ) 、亜鉛末(looq)および無水酢
酸亜鉛(15wg )のメタノール(4d)の溶液を2
2時間加熱還流する。反応終了後クロロホルム(’15
Ile)を加えてろ過し、亜鉛末を除く。クロロホルム
層を水(2a/x2)で洗い、無水硫酸ナトリウムで乾
燥する。乾燥後溶媒を減圧下留去して得られる残留物を
シリカゲルカラムクロマトグラフィー(流出溶媒;クロ
ロホルム;メタノール=20:l)に111する。収量
40岬(収率57%)
m、p、24B−252℃ Rf+=0.21(クロロ
ホルム:メタノール−20+1)
実施例2
a)4′−デメテルーエビボドフイロトキシン−β〜D
−2.3−ジー0−アセテルー4,6−エチリデングル
コシドの製法
(ユ) 亜鉛末−酢酸を用いるβ、β、β−トリクロル
エトキシカルボニル基の脱離
4′−β、β、β−トリクロルエトキシカルボニル−4
′−デメテルーエビボドフイロトキシンーβ−D−2,
3−ジーO−アセテルー4,6〜エチリデングルコシド
(200try )を酢酸−ジオキシン(4mLl:1
)に溶解させ、その溶液に亜鉛末(200η)を加えて
室温で1時間攪拌する。反応終了後酢酸エチル(15R
t)を加えて・ろ過する。酢酸エチル層を水(5ml×
2)で洗い無水硫酸ナトリウムで乾燥する。乾燥後溶媒
を減圧下留去して得られる油状物質に少量のメタノール
を加えると結晶化する。収量14c1wI0(収率8B
%)(2) 亜鉛末−メタノールを用いるβ、β、β
−トリクロルエトキシカルボニル基の脱離、
4′−β、β、β−トリクロルエトキシ力ルボニルー4
′−デメテルーエビボドフイロトキシンーβ−D−2,
3−ジー〇−アセチルー4.6−エテリデングする。反
応終了後酢酸エチル(lamg)を加えてろ過し、亜鉛
末を除く。酢酸エチル層を水(3ml×2)で洗い無水
硫酸ナトリウムで乾燥する。乾燥後溶媒を減圧下留去し
て得られる油状物質に少量のメタノールを加えると結晶
化する。収量57Tng(収率72%)
この化合物は(1)で得られた化合物とm−p、+
1.R1゜N、M、R,ともに一致した。Example 1 Method for producing 4'-demeter-evivodophyllotoxin-β-D-ethylidene glucoside 4'-β,β,β-trichloroethoxycarbonyl-4
'-demethyl-epipodophyllotoxy/-β-ri12,
A solution of 3-di0-7 cetyl-4.6-ethylidene glucoside (100wq), zinc dust (looq) and anhydrous zinc acetate (15wg) in methanol (4d) was
Heat to reflux for 2 hours. After the reaction was completed, chloroform ('15
Ile) and filter to remove zinc dust. The chloroform layer is washed with water (2a/x2) and dried over anhydrous sodium sulfate. After drying, the solvent was distilled off under reduced pressure and the resulting residue was subjected to silica gel column chromatography (effluent solvent: chloroform: methanol = 20:l). Yield 40 capes (yield 57%) m, p, 24B - 252°C Rf+ = 0.21 (chloroform: methanol - 20 + 1) Example 2 a) 4'-demeter-evibodophyllotoxin-β ~ D
-2. Process for producing 3-di-0-acetel-4,6-ethylidene glucoside (U) Elimination of β, β, β-trichloroethoxy carbonyl group using zinc dust-acetic acid 4'-β, β, β-trichloroethoxy carbonyl-4
'-demeter-evivodophyllotoxin-β-D-2,
3-di-O-acetel-4,6-ethylidene glucoside (200 tries) was mixed with acetic acid-dioxin (4 mL:1
), add zinc dust (200η) to the solution, and stir at room temperature for 1 hour. After the reaction is complete, ethyl acetate (15R
Add t) and filter. The ethyl acetate layer was diluted with water (5 ml
Wash with 2) and dry with anhydrous sodium sulfate. After drying, the solvent is distilled off under reduced pressure, and a small amount of methanol is added to the resulting oily substance, which crystallizes. Yield 14c1wI0 (Yield 8B
%) (2) β, β, β using zinc dust-methanol
-Elimination of trichloroethoxycarbonyl group, 4'-β,β,β-trichloroethoxycarbonyl group
'-demeter-evivodophyllotoxin-β-D-2,
3-G〇-acetyl-4.6-etheliding. After the reaction is completed, ethyl acetate (lamg) is added and filtered to remove zinc dust. The ethyl acetate layer was washed with water (3 ml x 2) and dried over anhydrous sodium sulfate. After drying, the solvent is distilled off under reduced pressure, and a small amount of methanol is added to the resulting oily substance, which crystallizes. Yield 57Tng (yield 72%) This compound is the compound obtained in (1) and m-p, +
1. R1°N, M, and R all matched.
b)4′−デメチル−エピポドフィロトキシン−β−り
一エチリデングルコシドの製法
上記a)で得られた4′−デメテルーエビボドフイロト
キシンーβ−D?−2,3−ジー〇−アセチルー4,6
−エテリデングルコシド(100η)および無水酢酸亜
鉛(15〜)のメタノール−テトラヒドロフラン(5m
l 4’+1)の溶液を22時間加熱還流する。反応
終了後クロロホルム(20alV)を加える。有機層を
水(3mex2)で洗い無水硫酸ナトリウムで乾燥する
。乾燥後溶媒を減圧下留去して得られる残留物をシリカ
ゲルカラムクロマトグラフィー(流出溶媒2クロロホル
ム:メタノールe−20: l )により精製する。収
量49η(収率71チ)
参考例
4′−β、β、β−トリクロルエトキシカルボニル−4
′−デメテルーエビボドフイロトキシンーβ−D−2,
3−ジーO−アセチルー4,6−エテリデングルコシド
の製法
(a) 4’−β、β、β−トリクロルエトキシカル
ボニル−4′−デメチル−エピポドフィロトキシンの製
法4′−デメチル−エピポドフィロトキシン(2f)を
無水塩化エチレン(3smt)に懸濁させ、ついで無水
ピリジン(440■)を加えだ後−20℃に冷やす。こ
の液にβ、β、β−トリクロルエトキシカルボニルクロ
リド(1,17F)の無水塩化エチレン(3Rt )の
溶液を30分間を要して滴下し、更に30分間攪拌反応
させる。反応終了後、反応溶液を水(20mex2)で
洗い有機層を無水硫酸ナトリウムで乾燥する。乾燥後減
圧下に溶媒を留去して得られる粗製生成物をアセトン/
エーテルから再結晶する。収量2.a4f(収率92チ
)。b) Process for producing 4'-demethyl-epipodophyllotoxin-β-ethylidene glucoside 4'-demeter-epipodophyllotoxin-β-D? obtained in a) above? -2,3-G〇-acetyl-4,6
- methanol-tetrahydrofuran (5 m
The solution of l 4'+1) is heated to reflux for 22 hours. After the reaction is complete, chloroform (20 alV) is added. The organic layer was washed with water (3mex2) and dried over anhydrous sodium sulfate. After drying, the solvent is distilled off under reduced pressure, and the resulting residue is purified by silica gel column chromatography (eluent solvent: 2 chloroform: methanol e-20: l). Yield: 49η (yield: 71cm) Reference example 4'-β,β,β-trichloroethoxycarbonyl-4
'-demeter-evivodophyllotoxin-β-D-2,
Process for producing 3-di-O-acetyl-4,6-ethelidene glucoside (a) Process for producing 4'-β,β,β-trichloroethoxycarbonyl-4'-demethyl-epipodophyllotoxin 4'-demethyl-epipodyl Dophyllotoxin (2f) was suspended in anhydrous ethylene chloride (3smt), then anhydrous pyridine (440 ml) was added and cooled to -20°C. A solution of β, β, β-trichloroethoxycarbonyl chloride (1,17F) in anhydrous ethylene chloride (3Rt) was added dropwise to this solution over a period of 30 minutes, and the reaction was stirred for an additional 30 minutes. After the reaction is completed, the reaction solution is washed with water (20mex2) and the organic layer is dried over anhydrous sodium sulfate. After drying, the solvent was distilled off under reduced pressure, and the resulting crude product was mixed with acetone/
Recrystallize from ether. Yield 2. a4f (yield 92cm).
更にfPIgするにはメタノールから再結晶する。For further fPIg, recrystallize from methanol.
m、p、 141−142℃と219−220℃の二
重融点をもつ
1、R,’))Nujol 3540,3425.
ll7s5゜aX
1’/60,16□。cm−1
N、M、R(CDCl3 ) J 3−’73 (64
B ) OCH2X 2(tit 4’−β、β、
β−トリクロルエトキシカルボニル−41−デメテルー
エビボドフイロトキシ7−β−D−2,3−ジー0−ア
セチル−4,6−エチリデングルコシドの製造
4′−β、β、β−トリクロルエトキシカルボニル−4
′−デメチル−エピポドフィロトキシン(5’i’5.
4■)ヲ無水塩化エチレン(4me)に加熱して溶解さ
せ次いでこの溶液を20℃に冷却し、攪拌しながら4.
6−0−エチリデン−2,3−ジー0−アセ、チルーβ
−D−、/ルコピラノース(320q)を加え糖成分が
溶解するまで20℃で攪拌する。m, p, 1, R,')) Nujol 3540, 3425. with dual melting points of 141-142°C and 219-220°C.
ll7s5゜aX 1'/60,16□. cm-1 N, M, R (CDCl3) J 3-'73 (64
B) OCH2X 2 (tit 4'-β, β,
Preparation of β-trichloroethoxycarbonyl-41-demeter-evibodophyllotoxy 7-β-D-2,3-di-0-acetyl-4,6-ethylidene glucoside 4'-β,β,β-trichloroethoxycarbonyl -4
'-Demethyl-epipodophyllotoxin (5'i'5.
4) Dissolve it in anhydrous ethylene chloride (4me) by heating, then cool the solution to 20°C, and while stirring, 4.
6-0-ethylidene-2,3-di-0-ace, thiru β
-D-,/Lucopyranose (320q) was added and stirred at 20°C until the sugar component was dissolved.
溶解したら反応液を直ちに一20℃に冷却し三弗化ホウ
素エーテレート(0−3,5at、 48%BF3)
を滴下し、ついで−20℃で40分間攪拌する。Once dissolved, the reaction solution was immediately cooled to -20°C and boron trifluoride etherate (0-3,5at, 48% BF3)
was added dropwise, and then stirred at -20°C for 40 minutes.
無水ピリジン(0,35,tttl )の塩化エチレン
(1,ml)の溶液を攪拌、冷却しながら満願する。反
応液に塩化エチレン(104g)を加え、水(lodx
3)で洗い有機層を無水硫酸す) IJウムで乾燥する
。A solution of anhydrous pyridine (0,35,tttl) in ethylene chloride (1, ml) is stirred and cooled. Ethylene chloride (104g) was added to the reaction solution, and water (lodx
3) Wash the organic layer with anhydrous sulfuric acid and dry with IJum.
乾燥後溶媒を減圧下で留去し得られる粘稠性物質をシリ
ガゲルクロマトグラフイー(流出溶媒:トルエン:酢酸
エチル−4:1)により精製すると目的物が白い泡とし
て得られる。収量790■、(収率93チ)
更に精製するにはメタノールから再結晶を行う。After drying, the solvent is distilled off under reduced pressure and the resulting viscous substance is purified by silica gel chromatography (eluent: toluene:ethyl acetate - 4:1) to obtain the desired product as a white foam. Yield: 790 cm (Yield: 93 cm) For further purification, recrystallization from methanol is performed.
m、p、 166−168℃
2.05(3H,S) O−CCHん林−
3、’70(6H,S) −ocn3x2特許出願人
日本”化薬株式会社m, p, 166-168℃ 2.05 (3H, S) O-CCH Nrin-3, '70 (6H, S) -ocn3x2 Patent applicant Nippon Kayaku Co., Ltd.
Claims (1)
ロゲンを示し、mは0−2の!Ia%nはl−3の整数
であり、かつm +n c= 3である〕で表わされる
4′−ハロゲノエトキシカルボニル−4′−デメチル−
エピポドフィロトキシン−β−D−2・3−ジー0−ア
シル一番・6−ニチリデングルコシドのアシル基をアル
コリシスにより、又ハロゲノエトキシカルボニル基を還
元により除去することを特徴とする式 〔式中mθは前記と同じ〕で表わされる4′−デメチル
エピポドフィロトキシン−β−り一エテリデングルコシ
ドの製造法。[Claims] 1. Formula [In the formula, Ac represents an acyl group, mθ represents a methyl group, and X...
Indicates rogen, m is 0-2! 4'-halogenoethoxycarbonyl-4'-demethyl-
A formula characterized in that the acyl group of epipodophyllotoxin-β-D-2-3-di-0-acyl-ichiban-6-nitylidene glucoside is removed by alcoholysis and the halogenoethoxycarbonyl group is removed by reduction [ A method for producing 4'-demethylepipodophyllotoxin-β-ri-etheridene glucoside represented by the formula, mθ is the same as above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10138982A JPS58219196A (en) | 1982-06-15 | 1982-06-15 | Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10138982A JPS58219196A (en) | 1982-06-15 | 1982-06-15 | Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucoside |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58219196A true JPS58219196A (en) | 1983-12-20 |
JPH023797B2 JPH023797B2 (en) | 1990-01-24 |
Family
ID=14299394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10138982A Granted JPS58219196A (en) | 1982-06-15 | 1982-06-15 | Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucoside |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58219196A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162701A2 (en) * | 1984-05-22 | 1985-11-27 | Nippon Kayaku Kabushiki Kaisha | Process for producing etoposide and intermediate for use therein |
US4935504A (en) * | 1987-12-18 | 1990-06-19 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-acyl derivatives |
EP0401800A2 (en) * | 1989-06-07 | 1990-12-12 | Bristol-Myers Squibb Company | Acylated derivatives of etoposide |
FR2655047A1 (en) * | 1989-11-24 | 1991-05-31 | Pf Medicament | ETOPOSIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS SYNTHESIS INTERMEDIATES. |
US5066645A (en) * | 1989-09-01 | 1991-11-19 | Bristol-Myers Company | Epipodophyllotoxin altroside derivatives |
US8859756B2 (en) | 2010-03-31 | 2014-10-14 | Gilead Pharmasset Llc | Stereoselective synthesis of phosphorus containing actives |
US8957045B2 (en) | 2008-12-23 | 2015-02-17 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
US9045520B2 (en) | 2008-12-23 | 2015-06-02 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
-
1982
- 1982-06-15 JP JP10138982A patent/JPS58219196A/en active Granted
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0162701A2 (en) * | 1984-05-22 | 1985-11-27 | Nippon Kayaku Kabushiki Kaisha | Process for producing etoposide and intermediate for use therein |
US4935504A (en) * | 1987-12-18 | 1990-06-19 | Bristol-Myers Company | Epipodophyllotoxin glucoside 4'-acyl derivatives |
EP0401800A2 (en) * | 1989-06-07 | 1990-12-12 | Bristol-Myers Squibb Company | Acylated derivatives of etoposide |
US5036055A (en) * | 1989-06-07 | 1991-07-30 | Bristol-Myers Company | Acylated derivatives of etoposide |
US5066645A (en) * | 1989-09-01 | 1991-11-19 | Bristol-Myers Company | Epipodophyllotoxin altroside derivatives |
FR2655047A1 (en) * | 1989-11-24 | 1991-05-31 | Pf Medicament | ETOPOSIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS SYNTHESIS INTERMEDIATES. |
US8957045B2 (en) | 2008-12-23 | 2015-02-17 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
US9045520B2 (en) | 2008-12-23 | 2015-06-02 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
US8859756B2 (en) | 2010-03-31 | 2014-10-14 | Gilead Pharmasset Llc | Stereoselective synthesis of phosphorus containing actives |
Also Published As
Publication number | Publication date |
---|---|
JPH023797B2 (en) | 1990-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6032799A (en) | Novel 4'-demethyl-4-epipodophyllotoxin derivative | |
JPS6345293A (en) | Sialosylceramide compound and production thereof | |
JPS58219196A (en) | Production of 4'-demethyl-epipodophyllotoxin-beta-d- ethylideneglucoside | |
AU775831B2 (en) | Process for preparing 17alpha-acetoxy-11beta-(4-N,N-(dimethylamino)phenyl)-21- methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates | |
JP2001247594A (en) | Method of producing flavonoid compound | |
US5594158A (en) | Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin | |
JPH0331297A (en) | Manufacture of zigogenin. beta-cellopiocide | |
JPH023798B2 (en) | ||
JPS61129197A (en) | Manufacture of pregnane derivative and ester of novel androstane derivative | |
JPS63141992A (en) | Novel anthracycline derivative and production thereof | |
JPH08208688A (en) | Production of ginsenoside rh2 | |
JPH02292295A (en) | Preparation of etoposide | |
JPS59141596A (en) | 3-o-acyl-4"-deoxydesmycosin derivative and its preparation | |
JPS6219589A (en) | Production of hamaudol | |
JPS59212500A (en) | Novel process for preparation of 4'-demethyl- epipodophyllotoxin-beta-d-ethylydene glucoside | |
JP2009513526A (en) | Steroid-modified chacotriose and soratriose | |
JPS597183A (en) | Naphthacenequinone derivative and its preparation | |
JPS6051472B2 (en) | 3,4-dihydrocarbostyryl derivative | |
JPH0543545A (en) | New aza-saccharide derivative | |
JPH05239062A (en) | Synthesis of intermediate for synthesizing mycalamide | |
JPS61152665A (en) | Hexa-substituted benzene derivative | |
JPH0154359B2 (en) | ||
JPS62116578A (en) | Production of isosilybin | |
JP2009513527A (en) | Steroid-modified solatriose | |
JPS5862187A (en) | Production of 6-hydroxymethyluridine |